Literature DB >> 14734723

Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism.

Hong Xu1, Paula M Chilton, Yiming Huang, Carrie L Schanie, Suzanne T Ildstad.   

Abstract

Nonmyeloablative conditioning has significantly reduced the morbidity associated with bone marrow transplantation. The donor hemopoietic cell lineage(s) responsible for the induction and maintenance of tolerance in nonmyeloablatively conditioned recipients is not defined. In the present studies we evaluated which hemopoietic stem cell-derived components are critical to the induction of tolerance in a total body irradiation-based model. Recipient B10 mice were pretreated with mAbs and transplanted with allogeneic B10.BR bone marrow after conditioning with 100-300 cGy total body irradiation. The proportion of recipients engrafting increased in a dose-dependent fashion. All chimeric recipients exhibited multilineage donor cell production. However, induction of tolerance correlated strictly with early production of donor T cells. The chimeras without donor T cells rejected donor skin grafts and demonstrated strong antidonor reactivity in vitro, while possessing high levels of donor chimerism. These animals lost chimerism within 8 mo. Differentiation into T cells was aborted at a prethymic stage in recipients that did not produce donor T cells. Moreover, donor Ag-driven clonal deletion of recipient T cells occurred only in chimeras with donor T cells. These results demonstrate that donor T cell production is critical in the induction of transplantation tolerance and the maintenance of durable chimerism. In addition, donor T cell production directly correlates with the deletion of potentially alloreactive cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734723     DOI: 10.4049/jimmunol.172.3.1463

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Sensitization to minor antigens is a significant barrier in bone marrow transplantation and is prevented by CD154:CD40 blockade.

Authors:  H Xu; Y Huang; L R Hussain; Z Zhu; L D Bozulic; C Ding; J Yan; S T Ildstad
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

2.  Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients.

Authors:  Hong Xu; Paula M Chilton; Michael K Tanner; Yiming Huang; Carrie L Schanie; Mariano Dy-Liacco; Jun Yan; Suzanne T Ildstad
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

3.  Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization.

Authors:  Hong Xu; Jun Yan; Yiming Huang; Paula M Chilton; Chuanlin Ding; Carrie L Schanie; Li Wang; Suzanne T Ildstad
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

Review 4.  Composite tissue transplantation: a rapidly advancing field.

Authors:  K V Ravindra; S Wu; L Bozulic; H Xu; W C Breidenbach; S T Ildstad
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

Review 5.  Operational tolerance in kidney transplantation and associated biomarkers.

Authors:  A Massart; L Ghisdal; M Abramowicz; D Abramowicz
Journal:  Clin Exp Immunol       Date:  2017-05-29       Impact factor: 4.330

6.  Differential outcomes in prediabetic vs. overtly diabetic NOD mice nonmyeloablatively conditioned with costimulatory blockade.

Authors:  Larry D Bozulic; Yiming Huang; Hong Xu; Yujie Wen; Suzanne T Ildstad
Journal:  Exp Hematol       Date:  2011-07-01       Impact factor: 3.084

7.  Transplantation: is donor T-cell engraftment a biomarker for tolerance?

Authors:  Hong Xu; Suzanne T Ildstad
Journal:  Nat Rev Nephrol       Date:  2012-08-07       Impact factor: 28.314

8.  Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.

Authors:  Joseph Leventhal; Michael Abecassis; Joshua Miller; Lorenzo Gallon; Kadiyala Ravindra; David J Tollerud; Bradley King; Mary Jane Elliott; Geoffrey Herzig; Roger Herzig; Suzanne T Ildstad
Journal:  Sci Transl Med       Date:  2012-03-07       Impact factor: 17.956

9.  Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.

Authors:  Joseph Leventhal; Michael Abecassis; Joshua Miller; Lorenzo Gallon; David Tollerud; Mary Jane Elliott; Larry D Bozulic; Christopher Houston; Nedjema Sustento-Reodica; Suzanne T Ildstad
Journal:  Transplantation       Date:  2013-01-15       Impact factor: 4.939

10.  Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone.

Authors:  Dina N Rahhal; Hong Xu; Wei-Chao Huang; Shengli Wu; Yujie Wen; Yiming Huang; Suzanne T Ildstad
Journal:  Transplantation       Date:  2009-09-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.